Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Fennec Pharmaceuticals Inc (FENC)
Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 240,089
  • Shares Outstanding, K 27,037
  • Annual Sales, $ 1,540 K
  • Annual Income, $ -23,710 K
  • 60-Month Beta 0.37
  • Price/Sales 18.40
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FENC with:

Options Overview Details

View History
  • Implied Volatility 124.63% ( +30.82%)
  • Historical Volatility 35.14%
  • IV Percentile 90%
  • IV Rank 75.52%
  • IV High 157.28% on 02/06/24
  • IV Low 23.90% on 12/18/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 15
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 458
  • Open Int (30-Day) 718

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.00
  • Number of Estimates 3
  • High Estimate 0.02
  • Low Estimate -0.02
  • Prior Year -0.26
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.59 +5.12%
on 02/21/24
10.54 -14.33%
on 01/25/24
-1.22 (-11.90%)
since 01/22/24
3-Month
8.33 +8.40%
on 11/27/23
11.92 -24.24%
on 12/28/23
+0.20 (+2.27%)
since 11/22/23
52-Week
6.30 +43.33%
on 10/06/23
11.92 -24.24%
on 12/28/23
-0.10 (-1.10%)
since 02/22/23

Most Recent Stories

More News
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Misses Revenue Estimates

Adherex Technologies Inc. (FENC) delivered earnings and revenue surprises of -9.52% and 10.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

FENC : 9.03 (+1.69%)
CHGCY : 18.7000 (-4.40%)
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Lags Revenue Estimates

Adherex Technologies Inc. (FENC) delivered earnings and revenue surprises of -8.33% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

FENC : 9.03 (+1.69%)
MTEM : 3.86 (-5.39%)
Why Earnings Season Could Be Great for Adherex Technologies (FENC)

Adherex Technologies (FENC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

FENC : 9.03 (+1.69%)
Feneca (FENC) Gets FDA Nod for Cancer-Related Hearing Loss Drug

Feneca Pharmaceuticals (FENC) receives FDA approval for Pedmark to reduce the risk of ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors.

AERI : 15.25 (+0.07%)
FENC : 9.03 (+1.69%)
SLNO : 48.61 (unch)
ACER : 0.6601 (-17.95%)
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor

~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of...

FRX.TO : 12.02 (-2.12%)
FENC : 9.03 (+1.69%)
Chart of the Day: Fennec Pharmaceuticals --- BioPharma

The Chart of the Day belongs to the healthcare biotech company Fennec Pharmaceuticals (FENC) Barchart's Top Stocks to Own list first by the most frequent number of new highs in the last month, then used...

FENC : 9.03 (+1.69%)
Has Bellus Health (BLU) Outpaced Other Medical Stocks This Year?

Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.

BLU : 14.74 (unch)
FENC : 9.03 (+1.69%)
Has Adherex Technologies (FENC) Outpaced Other Medical Stocks This Year?

Here is how Adherex Technologies Inc. (FENC) and U.S. Physical Therapy (USPH) have performed compared to their sector so far this year.

FENC : 9.03 (+1.69%)
USPH : 102.16 (+0.60%)
Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 14, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that...

FENC : 9.03 (+1.69%)
FRX.TO : 12.02 (-2.12%)
Are Medical Stocks Lagging Bellus Health (BLU) This Year?

Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.

BLU : 14.74 (unch)
FENC : 9.03 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 9.47
2nd Resistance Point 9.30
1st Resistance Point 9.17
Last Price 9.03
1st Support Level 8.87
2nd Support Level 8.70
3rd Support Level 8.57

See More

52-Week High 11.92
Fibonacci 61.8% 9.77
Fibonacci 50% 9.11
Last Price 9.03
Fibonacci 38.2% 8.45
52-Week Low 6.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar